NO994330L - Metode for behandling av en tumor - Google Patents
Metode for behandling av en tumorInfo
- Publication number
- NO994330L NO994330L NO994330A NO994330A NO994330L NO 994330 L NO994330 L NO 994330L NO 994330 A NO994330 A NO 994330A NO 994330 A NO994330 A NO 994330A NO 994330 L NO994330 L NO 994330L
- Authority
- NO
- Norway
- Prior art keywords
- mammal
- administering
- effective amount
- tumor
- treating
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 abstract 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 4
- 229930012538 Paclitaxel Natural products 0.000 abstract 2
- 229960001592 paclitaxel Drugs 0.000 abstract 2
- 229910052697 platinum Inorganic materials 0.000 abstract 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 2
- 230000002195 synergetic effect Effects 0.000 abstract 1
- ORYDPOVDJJZGHQ-UHFFFAOYSA-N tirapazamine Chemical compound C1=CC=CC2=[N+]([O-])C(N)=N[N+]([O-])=C21 ORYDPOVDJJZGHQ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81476997A | 1997-03-07 | 1997-03-07 | |
| PCT/US1998/003292 WO1998039009A1 (en) | 1997-03-07 | 1998-02-17 | Method of treating a tumor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO994330D0 NO994330D0 (no) | 1999-09-06 |
| NO994330L true NO994330L (no) | 1999-10-25 |
| NO324974B1 NO324974B1 (no) | 2008-01-14 |
Family
ID=25215967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19994330A NO324974B1 (no) | 1997-03-07 | 1999-09-06 | Anvendelse av 3-amino-1,2,4-benzotriazin-1,4-dioksyd/paclitaxel/platina for fremstilling av et preparat for behandling av et pattedyr som har en fast tumor samt kit inneholdende nevnte preparat. |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6063780A (no) |
| EP (1) | EP1014990B1 (no) |
| JP (1) | JP2001513110A (no) |
| AT (1) | ATE338553T1 (no) |
| AU (1) | AU6178198A (no) |
| BR (1) | BR9808221A (no) |
| CA (1) | CA2281807C (no) |
| DE (1) | DE69835824T2 (no) |
| DK (1) | DK1014990T3 (no) |
| ES (1) | ES2268764T3 (no) |
| HR (1) | HRP980095A2 (no) |
| NO (1) | NO324974B1 (no) |
| PT (1) | PT1014990E (no) |
| WO (1) | WO1998039009A1 (no) |
| ZA (1) | ZA981609B (no) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1014990B1 (en) * | 1997-03-07 | 2006-09-06 | Sanofi-Aventis U.S. LLC | Antitumor combination of 3-amino-1,2,4-benzotriazine 1,4-dioxide/paclitaxel/platinum |
| DK1121117T3 (da) * | 1998-10-14 | 2002-09-16 | Debiopharm Sa | Indpakning af et oxaliplatinholdigt præparat |
| DE19925211B4 (de) * | 1999-06-01 | 2006-01-12 | PBS Pharmaceutical Bulk Substances SA | Kit zur Herstellung einer Formulierung von Paclitaxel |
| US7070796B1 (en) | 1999-08-30 | 2006-07-04 | Debiopharm S.A. | Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| DE60005376T2 (de) * | 1999-08-30 | 2004-07-01 | Debiopharm S.A. | Oxaliplatinhaltige parenteral anzuwendende stabilisierte arzneizubereitung und verfahren zu deren herstellung |
| WO2002047725A2 (fr) | 2000-12-12 | 2002-06-20 | Debiopharm S.A. | Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation |
| US6476068B1 (en) | 2001-12-06 | 2002-11-05 | Pharmacia Italia, S.P.A. | Platinum derivative pharmaceutical formulations |
| AU2003261354A1 (en) * | 2002-08-02 | 2004-02-23 | The Regents Of The University Of California | New uses for inhibitors of inosine monophosphate dehydrogenase |
| US20080107721A1 (en) * | 2003-05-20 | 2008-05-08 | Jonathan Lewis | Combination Chemotherapy Comprising A Liposomal Platinum Complex |
| US7989490B2 (en) | 2004-06-02 | 2011-08-02 | Cordis Corporation | Injectable formulations of taxanes for cad treatment |
| US20060275331A1 (en) * | 2004-08-31 | 2006-12-07 | Borek Zaludek | Pharmaceutical composition, method of manufacturing and therapeutic use thereof |
| JP2006248978A (ja) | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | 新規なリポソーム製剤 |
| JP2009510165A (ja) * | 2005-10-03 | 2009-03-12 | ジェネティックス ファーマシューティカルズ， インク． | 低酸素細胞を選択的に枯渇させるための方法 |
| US20070212360A1 (en) * | 2006-01-17 | 2007-09-13 | Denko Nicholas C | Modulation of mitochondrial oxygen consumption for therapeutic purposes |
| US8026017B2 (en) | 2007-03-16 | 2011-09-27 | The United States Of America As Represented By The Secretary Of The Army | High voltage methanol fuel cell assembly using proton exchange membranes and base/acid electrolytes |
| KR101925436B1 (ko) | 2008-04-10 | 2018-12-05 | 버지니아 커먼웰스 유니버시티 | 암 치료를 위한 종양 저 산소 상태의 유도 |
| US9278124B2 (en) | 2012-10-16 | 2016-03-08 | Halozyme, Inc. | Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
| EP4201403A1 (en) * | 2021-12-21 | 2023-06-28 | Som Innovation Biotech, S.L. | Compounds tirapazamine and quazinone for use in the treatment of gm2 gangliosidoses |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399363A (en) * | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US5484612A (en) * | 1993-09-22 | 1996-01-16 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin |
| EP1014990B1 (en) * | 1997-03-07 | 2006-09-06 | Sanofi-Aventis U.S. LLC | Antitumor combination of 3-amino-1,2,4-benzotriazine 1,4-dioxide/paclitaxel/platinum |
-
1998
- 1998-02-17 EP EP98906594A patent/EP1014990B1/en not_active Expired - Lifetime
- 1998-02-17 BR BR9808221-3A patent/BR9808221A/pt not_active Application Discontinuation
- 1998-02-17 CA CA002281807A patent/CA2281807C/en not_active Expired - Fee Related
- 1998-02-17 AU AU61781/98A patent/AU6178198A/en not_active Abandoned
- 1998-02-17 AT AT98906594T patent/ATE338553T1/de not_active IP Right Cessation
- 1998-02-17 WO PCT/US1998/003292 patent/WO1998039009A1/en not_active Ceased
- 1998-02-17 JP JP53855198A patent/JP2001513110A/ja not_active Ceased
- 1998-02-17 ES ES98906594T patent/ES2268764T3/es not_active Expired - Lifetime
- 1998-02-17 DE DE69835824T patent/DE69835824T2/de not_active Expired - Fee Related
- 1998-02-17 DK DK98906594T patent/DK1014990T3/da active
- 1998-02-17 PT PT98906594T patent/PT1014990E/pt unknown
- 1998-02-25 HR HR08/814,769A patent/HRP980095A2/hr not_active Application Discontinuation
- 1998-02-26 ZA ZA981609A patent/ZA981609B/xx unknown
- 1998-02-27 US US09/031,692 patent/US6063780A/en not_active Expired - Fee Related
-
1999
- 1999-09-06 NO NO19994330A patent/NO324974B1/no unknown
-
2000
- 2000-02-16 US US09/505,043 patent/US6319923B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6319923B1 (en) | 2001-11-20 |
| JP2001513110A (ja) | 2001-08-28 |
| PT1014990E (pt) | 2006-11-30 |
| NO324974B1 (no) | 2008-01-14 |
| DK1014990T3 (da) | 2006-12-11 |
| HRP980095A2 (en) | 1998-12-31 |
| DE69835824T2 (de) | 2007-03-29 |
| US6063780A (en) | 2000-05-16 |
| ES2268764T3 (es) | 2007-03-16 |
| ATE338553T1 (de) | 2006-09-15 |
| EP1014990A4 (en) | 2004-03-24 |
| NO994330D0 (no) | 1999-09-06 |
| CA2281807C (en) | 2007-10-16 |
| EP1014990A1 (en) | 2000-07-05 |
| ZA981609B (en) | 1998-12-08 |
| BR9808221A (pt) | 2000-05-16 |
| WO1998039009A1 (en) | 1998-09-11 |
| AU6178198A (en) | 1998-09-22 |
| DE69835824D1 (de) | 2006-10-19 |
| EP1014990B1 (en) | 2006-09-06 |
| CA2281807A1 (en) | 1998-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO994330L (no) | Metode for behandling av en tumor | |
| DK1068870T3 (da) | Antitumormidler | |
| PT882021E (pt) | Novas fenantridinas | |
| ATE288749T1 (de) | Verwendung von kannabidiol als entzündunghemmende mittel | |
| FI972086A7 (fi) | Parannetun monilääkeresistenssiaktiivisuuden omaavat uudet aminohappoj ohdokset | |
| ATE207355T1 (de) | Behandlung von hyperproliferativen gefässerkrankungen | |
| EA199900620A1 (ru) | Фталазиноны | |
| PT880350E (pt) | Tratamento de esclerose multipla | |
| DE69807349D1 (de) | Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren | |
| ATE258796T1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| PT902789E (pt) | Derivados de androsteno | |
| BG100510A (en) | Method of treating androgenic alopecia with 5-alpha reductase inhibitors | |
| PL340679A1 (en) | Application of a mixture of diole and alpha-hydroxyacid in treating | |
| EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| ATE317263T1 (de) | Diphosphonat derivate von therapeutisch wirksamen stoffen | |
| ATE293972T1 (de) | Behandlung von chronischen schmerzen | |
| DE69814691D1 (de) | Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten | |
| ATE204476T1 (de) | Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem | |
| RU94024337A (ru) | Антиметастатическое средство | |
| ATE200026T1 (de) | Behandlung von laminitis | |
| ATE271867T1 (de) | Behandlung der harninkontinenz und zusammenstellung dafür |